Fund Name | Location |
Access Biotechnology | New York, New York, United States |
Association of International Certified Professional Accountants | Durham, North Carolina, United States |
B612 Participations | France, Lyon, Rhone-Alpes |
Capital Development Investment Fund | Beijing, Beijing, China |
Conister Bank | Isle of Man, Middle, NA - Isle of Man |
Dongfeng Motor Group | China, Hubei, Wuhan |
Inovio Pharmaceuticals | Pennsylvania, Plymouth Meeting, United States |
M3 Investimentos | - |
McGraw-Hill Education | Columbus, Ohio, United States |
Mutschler Ventures AG | Baar, Switzerland, Zug |
Prosper Capital | - |
Rathbone Greenbank | Bristol, England, United Kingdom |
Saudi Aramco Entrepreneurship Ventures | Ash Sharqiyah, Dhahran, Saudi Arabia |
Shangyan Jingji Zixun | - |
Thomas Weisel Venture Partners | California, San Francisco, United States |
Tianyi Chuangtou | China, Shanghai |
Tongmeng Touzi | Beijing, China, Haidian |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.